Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial.
A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial. Gynecol Oncol. 2005 Oct; 99(1):50-7.
View in:
PubMed
subject areas
Aged
Aged
Amino Acid Sequence
Amino Acid Sequence
Antineoplastic Agents
Antineoplastic Agents
Biomarkers, Tumor
Biomarkers, Tumor
Dose-Response Relationship, Drug
Dose-Response Relationship, Drug
Female
Female
Genital Neoplasms, Female
Genital Neoplasms, Female
Humans
Humans
Injections, Subcutaneous
Injections, Subcutaneous
Middle Aged
Middle Aged
Molecular Sequence Data
Molecular Sequence Data
Peptide Fragments
Peptide Fragments
Urokinase-Type Plasminogen Activator
Urokinase-Type Plasminogen Activator
authors with profiles
Michael A Gold